BEHANDLUNG VON LUNGENFIBROSE

European patent · EP4138798 · In force

Register entry

Publication number
EP4138798
Application number
EP21722978
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 20, 2021
Published
Mar 1, 2023
Granted
Jul 9, 2025
Protection ends at the latest
Apr 19, 2041
Next annual fee due
Apr 30, 2026
IPC classes
A61K 31/07 (2006.01)
A61P 11/00 (2006.01)
Priority
GB 202005727 20.04.2020
GB 202104041 23.03.2021
PCT application
PCT/GB2021/050948 20.04.2021
PCT publication
WO2021/214451 28.10.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 21, 2026

    Change

    Published in Swissreg on 21.05.2026

  2. Jul 9, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 09.07.2025

Parties

Holder

Regenall Limited

19 Harley Street, London W1G 9QJ, GB

Inventor

NOORDEEN, Mohamed Hamza

London Greater London W1G 9QJ, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.